SCOTUS just turned its back on Allergan’s legal maneuver to take a blow at inter partes review. What did you expect?
It’s finally over.
From the very beginning, Allergan’s attempt to safeguard its blockbuster Restasis franchise by handing over the patents to a Mohawk tribe …
